Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 8/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Peace Sandy on 2024-4-9
Source: Table 2 and Text
Description: 16S rRNA analysis showing the differences in the relative abundance of microbiota composition between Parkinson's disease Patients treated with L-dopa and Healthy Controls.
Abundance in Group 1: increased abundance in Parkinson's Disease Patients treated with L-dopa
| NCBI | Quality Control | Links |
|---|---|---|
| Enterococcaceae | ||
| Finegoldia | ||
| Peptoniphilus | ||
| Peptostreptococcaceae |
Revision editor(s): FaithAlexander, WikiWorks
